Pulse Biosciences EPS PLSE
Diluted earnings per share by quarter and over the last twelve months, from 2015.
- Last 12 months, to Sep 30, 2022
- −$2.03
- Latest quarter, Q3 FY22
- −$0.49
- Fiscal year 2021
- −$2.29
Pulse Biosciences' earnings per share was −$2.03 over the twelve months to Sep 30, 2022.
In its latest quarter, Q3 FY22, it was −$0.49.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2021 | −$2.29 | n/a |
| FY2020 | −$2.15 | n/a |
| FY2019 | −$2.27 | n/a |
| FY2018 | −$2.20 | n/a |
| FY2017 | −$1.71 | n/a |
| FY2016 | −$0.87 | n/a |
| FY2015 | −$0.37 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q3 FY22 | −$0.49 | n/a | −$2.03 | |
| Q2 FY22 | −$0.44 | n/a | −$2.02 | |
| Q1 FY22 | −$0.58 | n/a | −$2.16 | |
| Q4 FY21 | −$0.52 | n/a | −$2.29 | |
| Q3 FY21 | −$0.48 | n/a | −$2.31 | |
| Q2 FY21 | −$0.58 | n/a | −$2.34 | |
| Q1 FY21 | −$0.71 | n/a | −$2.29 | |
| Q4 FY20 | −$0.54 | n/a | −$2.15 | |
| Q3 FY20 | −$0.51 | n/a | −$2.27 | |
| Q2 FY20 | −$0.53 | n/a | −$2.33 | |
| Q1 FY20 | −$0.57 | n/a | −$2.35 | |
| Q4 FY19 | −$0.66 | n/a | −$2.27 |
Against its peers
Companies in Medical - Instruments & Supplies nearest Pulse Biosciences' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| PLSEPulse Biosciences | n/m | |
| NVSTEnvista | $0.58 | +81% a year |
| ICUIICU Medical | $1.18 | |
| BMIBadger Meter | $4.28 | −8% a year |
| WRBYWarby Parker | $0.07 | |
| VNTVontier | $2.41 | −8% a year |
| ATRCAtriCure | $0.21 | |
| HAEHaemonetics | $2.04 | −38% a year |
| MMSIMerit Medical Systems | $2.42 | +23% a year |
| UFPTUFP Technologies | $9.28 | +8% a year |
| INSPInspire Medical Systems | $4.62 | +166% a year |
| Peer median | $2.23 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Pulse Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.